IL2M International Corp. Closes of Merger with Aamani Healthcare Group

Rhea-AI Summary

IL2M International Corp. (OTC: ILIM) has successfully closed its merger with Aamani Healthcare Group, valued at $51.8 million. The acquisition, which completes by August 5, 2022, involved the issuance of two classes of shares, including 5 billion shares of common stock under a two-year lock-up agreement. Aamani, with a 2021 net income of $2.25 million and revenues of $6.08 million, specializes in Transitional Care and Home Health Services. This merger positions ILIM for future growth by leveraging Aamani's established healthcare services and client base.

Positive

• Merger with Aamani Healthcare Group valued at $51.8 million.
• Aamani reported 2021 net income of $2.25 million and revenue of $6.08 million.
• 5 billion shares of common stock under a two-year lock-up, limiting immediate dilution.

Negative

• None.

TORRANCE, Aug. 04, 2022 (GLOBE NEWSWIRE) -- IL2M International Corp. (OTC: ILIM) a Healthcare Technology holding company, today announced the closing of merger with Aamani Healthcare Group, a Houston, Texas based healthcare group specializing in Transitional Care Homes, Home Care Support Services, Home Health Care and Hospice Care. www.aamanihealthcare.com

ILIM merger closes this week, on or before August 5, 2022. All due diligence items have been completed and the final acquisition documents have been signed. All acquisition formalities bookkeeping items associated with the transfer of shares have been completed and our CEO’s holding has been finalized on the company's official shareholder records. Two classes of shares were used for the transaction: (a) the 2022 Series A Preferred (non-participatory and non-convertible), and (b) Five (5) billion shares of the Company’s common stock which are under LOCK-UP for two years. The shares used would not increase the float for a minimum of two years. After the expiration of the two year lock-up, traditional control-restriction would apply to the five (5) billion shares. The consolidated firm could run as a “holdco” or as a “joint-venture” wherein portfolio/acquired business operations go into the vehicle best suited for it based on management’s best judgment. All conditions precedent has been met and no material item is outstanding.

The deal is valued at $51.8 million based Aamani Healthcare Group has 2021 annual net income of $2.25 million, on Revenue of $6.08 million, leveraging as assets base of $11.96 million. The transaction multiple was based on industry 23, which in this particular industry was conservative considering the ILIM planned rollup and acquisitions.

About Aamani Healthcare Group

Aamani Healthcare Group serves an array of patients with different medical support needs and with age variations. By providing Transitional Care Homes, Home Care Support Services, Home Health Care and Hospice Care, we provide patient focus care plans to support the complexity of health care needs for their care continuum. The company was founded in 2013 by owner Kristin Oloso Esq. Who began her career in the legal department of an acute care hospital located in Gordo, AL. Her experience in the company includes providing guardianship, fiduciary, and specialized care management assistance to seniors and their families who face difficult life decisions.

About IL2M International Corp 

A Healthcare Technology holding company
Contact Information:

ILIM Shareholder/Investor inquiries can be directed to:
IL2M International Corp
Tel. 1.424.358.1046
Website: www.ilimcorp.com
Twitter: https://twitter.com/ILIMcorp

Safe Harbor Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE IL2M International Corp

FAQ

What was the value of ILIM's merger with Aamani Healthcare Group?

The merger was valued at $51.8 million.

When did ILIM officially close the merger with Aamani?

The merger officially closed on or before August 5, 2022.

What financial performance did Aamani Healthcare report in 2021?

Aamani Healthcare reported a net income of $2.25 million and revenue of $6.08 million in 2021.

What share classes were involved in the ILIM-Aamani merger?

The merger involved the issuance of 2022 Series A Preferred shares and 5 billion shares of common stock.

What is the significance of the two-year lock-up for the common shares?

The two-year lock-up prevents an increase in the stock float, limiting dilution for existing shareholders.